SCHLEIFER LEONARD S 1218629 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-15 | 2023-05-15 | 4 | Schleifer Leonard S | PRESIDENT & CEO | dsp | 53807.0 | 100.0 | 4.99 | 0.0 | 2021 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | code G | 0.0 | 107.89 (REGN) |
| 2023-05-17 | 2023-05-15 | 4 | Schleifer Leonard S | PRESIDENT & CEO | holding | 5916.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.89 (REGN) | ||
| 2023-05-17 | 2023-05-15 | 4 | Schleifer Leonard S | PRESIDENT & CEO | holding | 250000.0 | 0 | 23.17 | 0.0 | 2023 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.89 (REGN) | ||
| 2023-05-17 | 2023-05-15 | 2023-05-15 | 4 | Schleifer Leonard S | PRESIDENT & CEO | acq | 53807.0 | 82.8 | 4.99 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | code G | 64985.0 | 107.89 (REGN) |
| 2023-05-17 | 2023-05-15 | 4 | Schleifer Leonard S | PRESIDENT & CEO | holding | 362115.0 | 0 | 33.56 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.89 (REGN) | ||
| 2023-12-13 | 2023-12-11 | 2023-12-11 | 4 | Schleifer Leonard S | BD. CO-CHAIR, PRESIDENT & CEO | dsp | 12841.0 | 3.32 | 1.2 | 844.09 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 374429.0 | 107.13 (REGN) |
| 2023-12-13 | 2023-12-11 | 2023-12-11 | 4 | Schleifer Leonard S | BD. CO-CHAIR, PRESIDENT & CEO | acq | 25155.0 | 6.5 | 2.35 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 387270.0 | 107.13 (REGN) |
| 2023-12-13 | 2023-12-11 | 4 | Schleifer Leonard S | BD. CO-CHAIR, PRESIDENT & CEO | holding | 5916.0 | 0 | 0.55 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-13 | 2023-12-11 | 4 | Schleifer Leonard S | BD. CO-CHAIR, PRESIDENT & CEO | holding | 250000.0 | 0 | 23.34 | 0.0 | 2023 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-13 | 2023-12-11 | 4 | Schleifer Leonard S | BD. CO-CHAIR, PRESIDENT & CEO | holding | 64985.0 | 0 | 6.07 | 0.0 | By Trust | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-13 | 2023-12-11 | 2023-12-11 | 4 | Schleifer Leonard S | BD. CO-CHAIR, PRESIDENT & CEO | dsp | 25155.0 | 100.0 | 2.35 | 0.0 | Direct | 2019 Performance Stock Units | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.13 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)